
MeiraGTx Holdings plc Ordinary Shares
MGTX
MGTX: MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
moreShow MGTX Financials
Recent trades of MGTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by MGTX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on MGTX's company Twitter account
Number of mentions of MGTX in WallStreetBets Daily Discussion
Recent insights relating to MGTX
Recent picks made for MGTX stock on CNBC
ETFs with the largest estimated holdings in MGTX
Flights by private jets registered to MGTX